Recently, Luo et al showed the inhibitory role of interleukin-10 (IL-10) in BCG-induced macrophage cytotoxicity, suggesting that the blockage of IL-10 may potentially enhance the effect of BCG in the treatment of bladder cancer patients (11). This evidence concerns the gene IL10 and urinary bladder cancer.